Global Generic Medicine Market Size, Status and Forecast 2020-2026

Global Generic Medicine Market Size, Status and Forecast 2020-2026

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Generic Medicine Revenue
1.4 Market Analysis by Type
1.4.1 Global Generic Medicine Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Simple Generic Drugs
1.4.3 Super Generic Drugs
1.4.4 Biosimilars
1.4.5 By Application:
1.4.6 CNS
1.4.7 Cardiovascular
1.4.8 Respiratory
1.4.9 Rheumatology
1.4.10 Diabetes
1.4.11 Oncology
1.5 Market by Application
1.5.1 Global Generic Medicine Market Share by Application: 2020 VS 2026
1.5.2 CNS
1.5.3 Cardiovascular
1.5.4 Respiratory
1.5.5 Rheumatology
1.5.6 Diabetes
1.5.7 Oncology
1.5.8 Others
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends by Regions
2.1 Generic Medicine Market Perspective (2015-2026)
2.2 Generic Medicine Growth Trends by Regions
2.2.1 Generic Medicine Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Generic Medicine Historic Market Share by Regions (2015-2020)
2.2.3 Generic Medicine Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter's Five Forces Analysis
2.3.5 Generic Medicine Market Growth Strategy
2.3.6 Primary Interviews with Key Generic Medicine Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Generic Medicine Players by Market Size
3.1.1 Global Top Generic Medicine Players by Revenue (2015-2020)
3.1.2 Global Generic Medicine Revenue Market Share by Players (2015-2020)
3.1.3 Global Generic Medicine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Generic Medicine Market Concentration Ratio
3.2.1 Global Generic Medicine Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Generic Medicine Revenue in 2019
3.3 Generic Medicine Key Players Head office and Area Served
3.4 Key Players Generic Medicine Product Solution and Service
3.5 Date of Enter into Generic Medicine Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2015-2026)
4.1 Global Generic Medicine Historic Market Size by Type (2015-2020)
4.2 Global Generic Medicine Forecasted Market Size by Type (2021-2026)
5 Generic Medicine Breakdown Data by Application (2015-2026)
5.1 Global Generic Medicine Market Size by Application (2015-2020)
5.2 Global Generic Medicine Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Generic Medicine Market Size (2015-2020)
6.2 Generic Medicine Key Players in North America (2019-2020)
6.3 North America Generic Medicine Market Size by Type (2015-2020)
6.4 North America Generic Medicine Market Size by Application (2015-2020)
7 Europe
7.1 Europe Generic Medicine Market Size (2015-2020)
7.2 Generic Medicine Key Players in Europe (2019-2020)
7.3 Europe Generic Medicine Market Size by Type (2015-2020)
7.4 Europe Generic Medicine Market Size by Application (2015-2020)
8 China
8.1 China Generic Medicine Market Size (2015-2020)
8.2 Generic Medicine Key Players in China (2019-2020)
8.3 China Generic Medicine Market Size by Type (2015-2020)
8.4 China Generic Medicine Market Size by Application (2015-2020)
9 Japan
9.1 Japan Generic Medicine Market Size (2015-2020)
9.2 Generic Medicine Key Players in Japan (2019-2020)
9.3 Japan Generic Medicine Market Size by Type (2015-2020)
9.4 Japan Generic Medicine Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Generic Medicine Market Size (2015-2020)
10.2 Generic Medicine Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Generic Medicine Market Size by Type (2015-2020)
10.4 Southeast Asia Generic Medicine Market Size by Application (2015-2020)
11 India
11.1 India Generic Medicine Market Size (2015-2020)
11.2 Generic Medicine Key Players in India (2019-2020)
11.3 India Generic Medicine Market Size by Type (2015-2020)
11.4 India Generic Medicine Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Generic Medicine Market Size (2015-2020)
12.2 Generic Medicine Key Players in Central & South America (2019-2020)
12.3 Central & South America Generic Medicine Market Size by Type (2015-2020)
12.4 Central & South America Generic Medicine Market Size by Application (2015-2020)
13Key Players Profiles
13.1 Teva
13.1.1 Teva Company Details
13.1.2 Teva Business Overview and Its Total Revenue
13.1.3 Teva Generic Medicine Introduction
13.1.4 Teva Revenue in Generic Medicine Business (2015-2020))
13.1.5 Teva Recent Development
13.2 Novartis - Sandoz
13.2.1 Novartis - Sandoz Company Details
13.2.2 Novartis - Sandoz Business Overview and Its Total Revenue
13.2.3 Novartis - Sandoz Generic Medicine Introduction
13.2.4 Novartis - Sandoz Revenue in Generic Medicine Business (2015-2020)
13.2.5 Novartis - Sandoz Recent Development
13.3 Mylan
13.3.1 Mylan Company Details
13.3.2 Mylan Business Overview and Its Total Revenue
13.3.3 Mylan Generic Medicine Introduction
13.3.4 Mylan Revenue in Generic Medicine Business (2015-2020)
13.3.5 Mylan Recent Development
13.4 Sun Pharmaceutical
13.4.1 Sun Pharmaceutical Company Details
13.4.2 Sun Pharmaceutical Business Overview and Its Total Revenue
13.4.3 Sun Pharmaceutical Generic Medicine Introduction
13.4.4 Sun Pharmaceutical Revenue in Generic Medicine Business (2015-2020)
13.4.5 Sun Pharmaceutical Recent Development
13.5 Aspen
13.5.1 Aspen Company Details
13.5.2 Aspen Business Overview and Its Total Revenue
13.5.3 Aspen Generic Medicine Introduction
13.5.4 Aspen Revenue in Generic Medicine Business (2015-2020)
13.5.5 Aspen Recent Development
13.6 Fresenius Kabi
13.6.1 Fresenius Kabi Company Details
13.6.2 Fresenius Kabi Business Overview and Its Total Revenue
13.6.3 Fresenius Kabi Generic Medicine Introduction
13.6.4 Fresenius Kabi Revenue in Generic Medicine Business (2015-2020)
13.6.5 Fresenius Kabi Recent Development
13.7 Pfizer (Hospira)
13.7.1 Pfizer (Hospira) Company Details
13.7.2 Pfizer (Hospira) Business Overview and Its Total Revenue
13.7.3 Pfizer (Hospira) Generic Medicine Introduction
13.7.4 Pfizer (Hospira) Revenue in Generic Medicine Business (2015-2020)
13.7.5 Pfizer (Hospira) Recent Development
13.8 Sanofi
13.8.1 Sanofi Company Details
13.8.2 Sanofi Business Overview and Its Total Revenue
13.8.3 Sanofi Generic Medicine Introduction
13.8.4 Sanofi Revenue in Generic Medicine Business (2015-2020)
13.8.5 Sanofi Recent Development
13.9 Aurobindo
13.9.1 Aurobindo Company Details
13.9.2 Aurobindo Business Overview and Its Total Revenue
13.9.3 Aurobindo Generic Medicine Introduction
13.9.4 Aurobindo Revenue in Generic Medicine Business (2015-2020)
13.9.5 Aurobindo Recent Development
13.10 Lupin
13.10.1 Lupin Company Details
13.10.2 Lupin Business Overview and Its Total Revenue
13.10.3 Lupin Generic Medicine Introduction
13.10.4 Lupin Revenue in Generic Medicine Business (2015-2020)
13.10.5 Lupin Recent Development
13.11 Dr. Reddy's
10.11.1 Dr. Reddy's Company Details
10.11.2 Dr. Reddy's Business Overview and Its Total Revenue
10.11.3 Dr. Reddy's Generic Medicine Introduction
10.11.4 Dr. Reddy's Revenue in Generic Medicine Business (2015-2020)
10.11.5 Dr. Reddy's Recent Development
13.12 Apotex
10.12.1 Apotex Company Details
10.12.2 Apotex Business Overview and Its Total Revenue
10.12.3 Apotex Generic Medicine Introduction
10.12.4 Apotex Revenue in Generic Medicine Business (2015-2020)
10.12.5 Apotex Recent Development
13.13 Cipla
10.13.1 Cipla Company Details
10.13.2 Cipla Business Overview and Its Total Revenue
10.13.3 Cipla Generic Medicine Introduction
10.13.4 Cipla Revenue in Generic Medicine Business (2015-2020)
10.13.5 Cipla Recent Development
13.14 ENDO (Par Pharmaceutical)
10.14.1 ENDO (Par Pharmaceutical) Company Details
10.14.2 ENDO (Par Pharmaceutical) Business Overview and Its Total Revenue
10.14.3 ENDO (Par Pharmaceutical) Generic Medicine Introduction
10.14.4 ENDO (Par Pharmaceutical) Revenue in Generic Medicine Business (2015-2020)
10.14.5 ENDO (Par Pharmaceutical) Recent Development
13.15 Stada Arzneimittel
10.15.1 Stada Arzneimittel Company Details
10.15.2 Stada Arzneimittel Business Overview and Its Total Revenue
10.15.3 Stada Arzneimittel Generic Medicine Introduction
10.15.4 Stada Arzneimittel Revenue in Generic Medicine Business (2015-2020)
10.15.5 Stada Arzneimittel Recent Development
13.16 Krka Group
10.16.1 Krka Group Company Details
10.16.2 Krka Group Business Overview and Its Total Revenue
10.16.3 Krka Group Generic Medicine Introduction
10.16.4 Krka Group Revenue in Generic Medicine Business (2015-2020)
10.16.5 Krka Group Recent Development
13.17 Nichi-Iko Pharmaceutical
10.17.1 Nichi-Iko Pharmaceutical Company Details
10.17.2 Nichi-Iko Pharmaceutical Business Overview and Its Total Revenue
10.17.3 Nichi-Iko Pharmaceutical Generic Medicine Introduction
10.17.4 Nichi-Iko Pharmaceutical Revenue in Generic Medicine Business (2015-2020)
10.17.5 Nichi-Iko Pharmaceutical Recent Development
13.18 Valeant
10.18.1 Valeant Company Details
10.18.2 Valeant Business Overview and Its Total Revenue
10.18.3 Valeant Generic Medicine Introduction
10.18.4 Valeant Revenue in Generic Medicine Business (2015-2020)
10.18.5 Valeant Recent Development
13.19 Zydus Cadila
10.19.1 Zydus Cadila Company Details
10.19.2 Zydus Cadila Business Overview and Its Total Revenue
10.19.3 Zydus Cadila Generic Medicine Introduction
10.19.4 Zydus Cadila Revenue in Generic Medicine Business (2015-2020)
10.19.5 Zydus Cadila Recent Development
13.20 Hikma
10.20.1 Hikma Company Details
10.20.2 Hikma Business Overview and Its Total Revenue
10.20.3 Hikma Generic Medicine Introduction
10.20.4 Hikma Revenue in Generic Medicine Business (2015-2020)
10.20.5 Hikma Recent Development
14Analyst's Viewpoints/Conclusions
15Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
List of Tables
Table 1. Generic Medicine Key Market Segments
Table 2. Key Players Covered: Ranking by Generic Medicine Revenue
Table 3. Ranking of Global Top Generic Medicine Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Generic Medicine Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Simple Generic Drugs
Table 6. Key Players of Super Generic Drugs
Table 7. Key Players of Biosimilars
Table 8. Key Players of By Application:
Table 9. Key Players of CNS
Table 10. Key Players of Cardiovascular
Table 11. Key Players of Respiratory
Table 12. Key Players of Rheumatology
Table 13. Key Players of Diabetes
Table 14. Key Players of Oncology
Table 15. Global Generic Medicine Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 16. Global Generic Medicine Market Size by Regions (US$ Million): 2020 VS 2026
Table 17. Global Generic Medicine Market Size by Regions (2015-2020) (US$ Million)
Table 18. Global Generic Medicine Market Share by Regions (2015-2020)
Table 19. Global Generic Medicine Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 20. Global Generic Medicine Market Share by Regions (2021-2026)
Table 21. Market Top Trends
Table 22. Key Drivers: Impact Analysis
Table 23. Key Challenges
Table 24. Generic Medicine Market Growth Strategy
Table 25. Main Points Interviewed from Key Generic Medicine Players
Table 26. Global Generic Medicine Revenue by Players (2015-2020) (Million US$)
Table 27. Global Generic Medicine Market Share by Players (2015-2020)
Table 28. Global Top Generic Medicine Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Generic Medicine as of 2019)
Table 29. Global Generic Medicine by Players Market Concentration Ratio (CR5 and HHI)
Table 30. Key Players Headquarters and Area Served
Table 31. Key Players Generic Medicine Product Solution and Service
Table 32. Date of Enter into Generic Medicine Market
Table 33. Mergers & Acquisitions, Expansion Plans
Table 34. Global Generic Medicine Market Size by Type (2015-2020) (Million US$)
Table 35. Global Generic Medicine Market Size Share by Type (2015-2020)
Table 36. Global Generic Medicine Revenue Market Share by Type (2021-2026)
Table 37. Global Generic Medicine Market Size Share by Application (2015-2020)
Table 38. Global Generic Medicine Market Size by Application (2015-2020) (Million US$)
Table 39. Global Generic Medicine Market Size Share by Application (2021-2026)
Table 40. North America Key Players Generic Medicine Revenue (2019-2020) (Million US$)
Table 41. North America Key Players Generic Medicine Market Share (2019-2020)
Table 42. North America Generic Medicine Market Size by Type (2015-2020) (Million US$)
Table 43. North America Generic Medicine Market Share by Type (2015-2020)
Table 44. North America Generic Medicine Market Size by Application (2015-2020) (Million US$)
Table 45. North America Generic Medicine Market Share by Application (2015-2020)
Table 46. Europe Key Players Generic Medicine Revenue (2019-2020) (Million US$)
Table 47. Europe Key Players Generic Medicine Market Share (2019-2020)
Table 48. Europe Generic Medicine Market Size by Type (2015-2020) (Million US$)
Table 49. Europe Generic Medicine Market Share by Type (2015-2020)
Table 50. Europe Generic Medicine Market Size by Application (2015-2020) (Million US$)
Table 51. Europe Generic Medicine Market Share by Application (2015-2020)
Table 52. China Key Players Generic Medicine Revenue (2019-2020) (Million US$)
Table 53. China Key Players Generic Medicine Market Share (2019-2020)
Table 54. China Generic Medicine Market Size by Type (2015-2020) (Million US$)
Table 55. China Generic Medicine Market Share by Type (2015-2020)
Table 56. China Generic Medicine Market Size by Application (2015-2020) (Million US$)
Table 57. China Generic Medicine Market Share by Application (2015-2020)
Table 58. Japan Key Players Generic Medicine Revenue (2019-2020) (Million US$)
Table 59. Japan Key Players Generic Medicine Market Share (2019-2020)
Table 60. Japan Generic Medicine Market Size by Type (2015-2020) (Million US$)
Table 61. Japan Generic Medicine Market Share by Type (2015-2020)
Table 62. Japan Generic Medicine Market Size by Application (2015-2020) (Million US$)
Table 63. Japan Generic Medicine Market Share by Application (2015-2020)
Table 64. Southeast Asia Key Players Generic Medicine Revenue (2019-2020) (Million US$)
Table 65. Southeast Asia Key Players Generic Medicine Market Share (2019-2020)
Table 66. Southeast Asia Generic Medicine Market Size by Type (2015-2020) (Million US$)
Table 67. Southeast Asia Generic Medicine Market Share by Type (2015-2020)
Table 68. Southeast Asia Generic Medicine Market Size by Application (2015-2020) (Million US$)
Table 69. Southeast Asia Generic Medicine Market Share by Application (2015-2020)
Table 70. India Key Players Generic Medicine Revenue (2019-2020) (Million US$)
Table 71. India Key Players Generic Medicine Market Share (2019-2020)
Table 72. India Generic Medicine Market Size by Type (2015-2020) (Million US$)
Table 73. India Generic Medicine Market Share by Type (2015-2020)
Table 74. India Generic Medicine Market Size by Application (2015-2020) (Million US$)
Table 75. India Generic Medicine Market Share by Application (2015-2020)
Table 76. Central & South America Key Players Generic Medicine Revenue (2019-2020) (Million US$)
Table 77. Central & South America Key Players Generic Medicine Market Share (2019-2020)
Table 78. Central & South America Generic Medicine Market Size by Type (2015-2020) (Million US$)
Table 79. Central & South America Generic Medicine Market Share by Type (2015-2020)
Table 80. Central & South America Generic Medicine Market Size by Application (2015-2020) (Million US$)
Table 81. Central & South America Generic Medicine Market Share by Application (2015-2020)
Table 82. Teva Company Details
Table 83. Teva Business Overview
Table 84. Teva Product
Table 85. Teva Revenue in Generic Medicine Business (2015-2020) (Million US$)
Table 86. Teva Recent Development
Table 87. Novartis - Sandoz Company Details
Table 88. Novartis - Sandoz Business Overview
Table 89. Novartis - Sandoz Product
Table 90. Novartis - Sandoz Revenue in Generic Medicine Business (2015-2020) (Million US$)
Table 91. Novartis - Sandoz Recent Development
Table 92. Mylan Company Details
Table 93. Mylan Business Overview
Table 94. Mylan Product
Table 95. Mylan Revenue in Generic Medicine Business (2015-2020) (Million US$)
Table 96. Mylan Recent Development
Table 97. Sun Pharmaceutical Company Details
Table 98. Sun Pharmaceutical Business Overview
Table 99. Sun Pharmaceutical Product
Table 100. Sun Pharmaceutical Revenue in Generic Medicine Business (2015-2020) (Million US$)
Table 101. Sun Pharmaceutical Recent Development
Table 102. Aspen Company Details
Table 103. Aspen Business Overview
Table 104. Aspen Product
Table 105. Aspen Revenue in Generic Medicine Business (2015-2020) (Million US$)
Table 106. Aspen Recent Development
Table 107. Fresenius Kabi Company Details
Table 108. Fresenius Kabi Business Overview
Table 109. Fresenius Kabi Product
Table 110. Fresenius Kabi Revenue in Generic Medicine Business (2015-2020) (Million US$)
Table 111. Fresenius Kabi Recent Development
Table 112. Pfizer (Hospira) Company Details
Table 113. Pfizer (Hospira) Business Overview
Table 114. Pfizer (Hospira) Product
Table 115. Pfizer (Hospira) Revenue in Generic Medicine Business (2015-2020) (Million US$)
Table 116. Pfizer (Hospira) Recent Development
Table 117. Sanofi Business Overview
Table 118. Sanofi Product
Table 119. Sanofi Company Details
Table 120. Sanofi Revenue in Generic Medicine Business (2015-2020) (Million US$)
Table 121. Sanofi Recent Development
Table 122. Aurobindo Company Details
Table 123. Aurobindo Business Overview
Table 124. Aurobindo Product
Table 125. Aurobindo Revenue in Generic Medicine Business (2015-2020) (Million US$)
Table 126. Aurobindo Recent Development
Table 127. Lupin Company Details
Table 128. Lupin Business Overview
Table 129. Lupin Product
Table 130. Lupin Revenue in Generic Medicine Business (2015-2020) (Million US$)
Table 131. Lupin Recent Development
Table 132. Dr. Reddy's Company Details
Table 133. Dr. Reddy's Business Overview
Table 134. Dr. Reddy's Product
Table 135. Dr. Reddy's Revenue in Generic Medicine Business (2015-2020) (Million US$)
Table 136. Dr. Reddy's Recent Development
Table 137. Apotex Company Details
Table 138. Apotex Business Overview
Table 139. Apotex Product
Table 140. Apotex Revenue in Generic Medicine Business (2015-2020) (Million US$)
Table 141. Apotex Recent Development
Table 142. Cipla Company Details
Table 143. Cipla Business Overview
Table 144. Cipla Product
Table 145. Cipla Revenue in Generic Medicine Business (2015-2020) (Million US$)
Table 146. Cipla Recent Development
Table 147. ENDO (Par Pharmaceutical) Company Details
Table 148. ENDO (Par Pharmaceutical) Business Overview
Table 149. ENDO (Par Pharmaceutical) Product
Table 150. ENDO (Par Pharmaceutical) Revenue in Generic Medicine Business (2015-2020) (Million US$)
Table 151. ENDO (Par Pharmaceutical) Recent Development
Table 152. Stada Arzneimittel Company Details
Table 153. Stada Arzneimittel Business Overview
Table 154. Stada Arzneimittel Product
Table 155. Stada Arzneimittel Revenue in Generic Medicine Business (2015-2020) (Million US$)
Table 156. Stada Arzneimittel Recent Development
Table 157. Krka Group Company Details
Table 158. Krka Group Business Overview
Table 159. Krka Group Product
Table 160. Krka Group Revenue in Generic Medicine Business (2015-2020) (Million US$)
Table 161. Krka Group Recent Development
Table 162. Nichi-Iko Pharmaceutical Company Details
Table 163. Nichi-Iko Pharmaceutical Business Overview
Table 164. Nichi-Iko Pharmaceutical Product
Table 165. Nichi-Iko Pharmaceutical Revenue in Generic Medicine Business (2015-2020) (Million US$)
Table 166. Nichi-Iko Pharmaceutical Recent Development
Table 167. Valeant Company Details
Table 168. Valeant Business Overview
Table 169. Valeant Product
Table 170. Valeant Revenue in Generic Medicine Business (2015-2020) (Million US$)
Table 171. Valeant Recent Development
Table 172. Zydus Cadila Company Details
Table 173. Zydus Cadila Business Overview
Table 174. Zydus Cadila Product
Table 175. Zydus Cadila Revenue in Generic Medicine Business (2015-2020) (Million US$)
Table 176. Zydus Cadila Recent Development
Table 177. Hikma Company Details
Table 178. Hikma Business Overview
Table 179. Hikma Product
Table 180. Hikma Revenue in Generic Medicine Business (2015-2020) (Million US$)
Table 181. Hikma Recent Development
Table 182. Research Programs/Design for This Report
Table 183. Key Data Information from Secondary Sources
Table 184. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Generic Medicine Market Share by Type: 2020 VS 2026
Figure 2. Simple Generic Drugs Features
Figure 3. Super Generic Drugs Features
Figure 4. Biosimilars Features
Figure 5. By Application: Features
Figure 6. CNS Features
Figure 7. Cardiovascular Features
Figure 8. Respiratory Features
Figure 9. Rheumatology Features
Figure 10. Diabetes Features
Figure 11. Oncology Features
Figure 12. Global Generic Medicine Market Share by Application: 2020 VS 2026
Figure 13. CNS Case Studies
Figure 14. Cardiovascular Case Studies
Figure 15. Respiratory Case Studies
Figure 16. Rheumatology Case Studies
Figure 17. Diabetes Case Studies
Figure 18. Oncology Case Studies
Figure 19. Others Case Studies
Figure 20. Generic Medicine Report Years Considered
Figure 21. Global Generic Medicine Market Size YoY Growth 2015-2026 (US$ Million)
Figure 22. Global Generic Medicine Market Share by Regions: 2020 VS 2026
Figure 23. Global Generic Medicine Market Share by Regions (2021-2026)
Figure 24. Porter's Five Forces Analysis
Figure 25. Global Generic Medicine Market Share by Players in 2019
Figure 26. Global Top Generic Medicine Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Generic Medicine as of 2019
Figure 27. The Top 10 and 5 Players Market Share by Generic Medicine Revenue in 2019
Figure 28. North America Generic Medicine Market Size YoY Growth (2015-2020) (Million US$)
Figure 29. Europe Generic Medicine Market Size YoY Growth (2015-2020) (Million US$)
Figure 30. China Generic Medicine Market Size YoY Growth (2015-2020) (Million US$)
Figure 31. Japan Generic Medicine Market Size YoY Growth (2015-2020) (Million US$)
Figure 32. Southeast Asia Generic Medicine Market Size YoY Growth (2015-2020) (Million US$)
Figure 33. India Generic Medicine Market Size YoY Growth (2015-2020) (Million US$)
Figure 34. Central & South America Generic Medicine Market Size YoY Growth (2015-2020) (Million US$)
Figure 35. Teva Total Revenue (US$ Million): 2019 Compared with 2018
Figure 36. Teva Revenue Growth Rate in Generic Medicine Business (2015-2020)
Figure 37. Novartis - Sandoz Total Revenue (US$ Million): 2019 Compared with 2018
Figure 38. Novartis - Sandoz Revenue Growth Rate in Generic Medicine Business (2015-2020)
Figure 39. Mylan Total Revenue (US$ Million): 2019 Compared with 2018
Figure 40. Mylan Revenue Growth Rate in Generic Medicine Business (2015-2020)
Figure 41. Sun Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 42. Sun Pharmaceutical Revenue Growth Rate in Generic Medicine Business (2015-2020)
Figure 43. Aspen Total Revenue (US$ Million): 2019 Compared with 2018
Figure 44. Aspen Revenue Growth Rate in Generic Medicine Business (2015-2020)
Figure 45. Fresenius Kabi Total Revenue (US$ Million): 2019 Compared with 2018
Figure 46. Fresenius Kabi Revenue Growth Rate in Generic Medicine Business (2015-2020)
Figure 47. Pfizer (Hospira) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 48. Pfizer (Hospira) Revenue Growth Rate in Generic Medicine Business (2015-2020)
Figure 49. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. Sanofi Revenue Growth Rate in Generic Medicine Business (2015-2020)
Figure 51. Aurobindo Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. Aurobindo Revenue Growth Rate in Generic Medicine Business (2015-2020)
Figure 53. Lupin Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. Lupin Revenue Growth Rate in Generic Medicine Business (2015-2020)
Figure 55. Dr. Reddy's Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. Dr. Reddy's Revenue Growth Rate in Generic Medicine Business (2015-2020)
Figure 57. Apotex Total Revenue (US$ Million): 2019 Compared with 2018
Figure 58. Apotex Revenue Growth Rate in Generic Medicine Business (2015-2020)
Figure 59. Cipla Total Revenue (US$ Million): 2019 Compared with 2018
Figure 60. Cipla Revenue Growth Rate in Generic Medicine Business (2015-2020)
Figure 61. ENDO (Par Pharmaceutical) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 62. ENDO (Par Pharmaceutical) Revenue Growth Rate in Generic Medicine Business (2015-2020)
Figure 63. Stada Arzneimittel Total Revenue (US$ Million): 2019 Compared with 2018
Figure 64. Stada Arzneimittel Revenue Growth Rate in Generic Medicine Business (2015-2020)
Figure 65. Krka Group Total Revenue (US$ Million): 2019 Compared with 2018
Figure 66. Krka Group Revenue Growth Rate in Generic Medicine Business (2015-2020)
Figure 67. Nichi-Iko Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 68. Nichi-Iko Pharmaceutical Revenue Growth Rate in Generic Medicine Business (2015-2020)
Figure 69. Valeant Total Revenue (US$ Million): 2019 Compared with 2018
Figure 70. Valeant Revenue Growth Rate in Generic Medicine Business (2015-2020)
Figure 71. Zydus Cadila Total Revenue (US$ Million): 2019 Compared with 2018
Figure 72. Zydus Cadila Revenue Growth Rate in Generic Medicine Business (2015-2020)
Figure 73. Hikma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 74. Hikma Revenue Growth Rate in Generic Medicine Business (2015-2020)
Figure 75. Bottom-up and Top-down Approaches for This Report
Figure 76. Data Triangulation

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Antioxidant Vitamins Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100

The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......

Global Clavulanate Potassium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......

Global Amoxicillin Sodium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84

The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......

Global Melatonin Supplements Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......

Global Sleeping Pills (Prescription Drugs) Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93

The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......

Global Sleeping Pills Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Zinc Oral Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......

Global Zinc Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......

Global Anti-Infectives Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs